awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33607736-30321363-EB4B-48D3-850E-BEED3087699F
Q33607736-30321363-EB4B-48D3-850E-BEED3087699F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33607736-30321363-EB4B-48D3-850E-BEED3087699F
Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.
P2860
Q33607736-30321363-EB4B-48D3-850E-BEED3087699F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33607736-30321363-EB4B-48D3-850E-BEED3087699F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
01159728df17178e3e258a694b090a5cbf7fbfaa
P2860
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.